Profile data is unavailable for this security.
About the company
Shaanxi Kanghui Pharmaceutical Co Ltd is a China-based company mainly engaged in the manufacturing and distribution of pharmaceuticals. The Company operates three segments. The Pharmaceutical Manufacturing segment mainly engages in the research and development, production and sales of Chinese patent medicines, as well as the research and development, production and sales of Chinese herbal decoction pieces and pharmaceutical intermediates. The Pharmaceutical Distribution segment mainly engages in the wholesale business of biological products, blood products, medicines and Chinese medicinal materials other than vaccines, as well as a small amount of retail business of medicines. The Company also operates the Others segment.
- Revenue in CNY (TTM)513.23m
- Net income in CNY-183.84m
- Incorporated2009
- Employees906.00
- LocationShaanxi Kanghui Pharmaceutical Co LtdNo. 36 Yanzhi Road, Qindu DistrictXIANYANG 712000ChinaCHN
- Phone+86 2 933347561
- Fax+86 2 933347561
- Websitehttp://www.sxkh.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hunan Nucien Pharmaceutical Co Ltd | 119.87m | -353.70m | 2.38bn | 360.00 | -- | 2.74 | -- | 19.82 | -1.28 | -1.28 | 0.4362 | 3.16 | 0.0998 | 1.41 | 0.4888 | -- | -32.50 | -5.94 | -36.98 | -8.19 | 32.41 | 83.51 | -325.67 | -15.02 | 2.29 | -139.49 | 0.1562 | -- | -64.64 | -23.64 | -9,613.65 | -- | 35.48 | -- |
| Shaanxi Kanghui Pharmaceutical Co Ltd | 513.23m | -183.84m | 2.42bn | 906.00 | -- | 3.34 | -- | 4.72 | -1.84 | -1.84 | 5.14 | 7.26 | 0.2636 | 1.93 | 2.53 | 566,479.70 | -11.36 | -1.99 | -18.19 | -2.69 | 24.46 | 36.16 | -43.08 | -6.59 | 0.5483 | -2.10 | 0.4726 | -- | -16.54 | 5.42 | -242.62 | -- | -10.54 | -- |
| Jiangsu gdk Biotechnology Co Ltd | 116.56m | -126.51m | 2.47bn | 452.00 | -- | 2.07 | -- | 21.20 | -1.03 | -1.03 | 0.9461 | 9.67 | 0.0775 | 0.7322 | 1.14 | 257,878.40 | -8.42 | 1.65 | -9.84 | 2.14 | 60.80 | 73.17 | -108.54 | 7.56 | 1.83 | -- | 0.0465 | 53.80 | -39.96 | 3.77 | -31.71 | -- | 12.74 | -- |
| Zhejiang East Asia Pharmaceutical Co Ltd | 831.56m | -218.24m | 2.49bn | 1.75k | -- | 1.37 | -- | 2.99 | -1.97 | -1.97 | 7.34 | 15.80 | 0.2409 | 0.8634 | 5.60 | 475,447.80 | -6.33 | 2.47 | -8.09 | 3.12 | 25.78 | 24.66 | -26.25 | 5.78 | 0.7513 | -411.46 | 0.3533 | 42.92 | -11.66 | 3.93 | -183.02 | -- | 29.64 | -- |
| Hangzhou Tianmushan Phrmtcl ntrprs C Ltd | 251.56m | 33.15m | 2.50bn | 362.00 | 75.30 | 37.49 | -- | 9.92 | 0.2723 | 0.2723 | 2.07 | 0.5468 | 0.632 | 2.97 | 2.32 | 694,905.80 | 8.32 | -8.84 | 27.42 | -25.80 | 47.93 | 32.17 | 13.17 | -21.83 | 0.655 | 9.23 | 0.648 | -- | 78.44 | -6.06 | 139.83 | -21.36 | -26.32 | -- |
| Hainan Huluwa Pharmaceutical Grop Co Ltd | 902.48m | -369.56m | 2.76bn | 2.10k | -- | 4.01 | -- | 3.06 | -0.9236 | -0.9236 | 2.26 | 1.72 | 0.3055 | 1.74 | 1.60 | 429,141.60 | -12.36 | 0.2178 | -22.13 | 0.3739 | 31.53 | 54.80 | -40.47 | 0.3213 | 0.5566 | -6.97 | 0.6414 | 700.10 | -21.26 | 1.60 | -2,629.23 | -- | 21.75 | -- |
Data as of Feb 12 2026. Currency figures normalised to Shaanxi Kanghui Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.13%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fortune & Royal Asset Management Co., Ltd.as of 30 Jun 2025 | 20.60k | 0.04% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 20.00k | 0.04% |
| Nuode Asset Management Co., Ltd.as of 30 Jun 2025 | 14.00k | 0.03% |
| New China Fund Management Co., Ltd.as of 30 Jun 2025 | 13.40k | 0.03% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 0.00 | 0.00% |
| CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 2025 | 0.00 | 0.00% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 30 Nov 2025Source: FactSet Research Systems Inc.
